Thorsten Hage - Concepedia

Author

Thorsten Hage

BioCrea (Germany)

Also Known As

T. Hage, Thorsten Hage

Publications

841

Citations

H-Index

Concepts

All Affiliations

BioCrea (Germany)Pfizer (United States)University of Würzburg

About

Thorsten Hage is an author at BioCrea (Germany) specializing in medicine, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	395
2	Natural Sciences	2	2	135
3	Social Sciences	2	2	100
4	Biochemistry	2	2	135
5	Cell Biology	1	1	14

Thorsten Hage

Publications

827

Citations

H-Index

Page 1

	Year	Citations
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia Steven M. Grauer, Virginia Pulito, Rachel L. Navarra, Journal of Pharmacology and Experimental Therapeutics	2009	265
Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface Thorsten Hage, Walter Sebald, Peter Reinemer Cell Mosaic Binding InterfaceCrystal StructureCytokineImmunologyReceptor (Biochemistry)	1999	220
Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801 Olga A.H. Reneerkens, Kris Rutten, Eva Bollen, Behavioural Brain Research Cognitive ScienceNeuropsychologyMemory SystemBrain FunctionPhoshodiesterase Type 2	2012	86
Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction Bojiang Shen, Thorsten Hage, Walter Sebald European Journal of Biochemistry	1996	81
Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors Michael S. Malamas, Yike Ni, James Erdei, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetPharmaceutical ScienceBiochemistryMedicine	2011	72
Discovery of Imidazo[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors Norbert Höfgen, Hans Stange, Rudolf Schindler, Journal of Medicinal Chemistry Crystal StructureBioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical Chemistry	2010	63
Novel triazines as potent and selective phosphodiesterase 10A inhibitors Michael S. Malamas, Hans Stange, Rudolf Schindler, Bioorganic & Medicinal Chemistry Letters Inhibitory ActivityMedicinal ChemistryMedicinePharmacotherapyDrug Development	2012	26
Phosphodiesterase 2 Inhibitors Promote Axonal Outgrowth in Organotypic Slice Co-Cultures C. Heine, Katja Sygnecka, Nico Scherf, Neurosignals NeurotransmitterCell GrowthCellular NeurobiologyImage QuantificationCellular Physiology	2012	14

Page 1